Direkt zum Inhalt
Merck
  • Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry.

Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry.

Journal of virology (2006-05-30)
Sarah Murray, Carol L Nilsson, Joan T Hare, Mark R Emmett, Andrei Korostelev, Heather Ongley, Alan G Marshall, Michael S Chapman
ZUSAMMENFASSUNG

Adeno-associated virus type 2 (AAV-2) capsid proteins have eight sequence motifs that are potential sites for O- or N-linked glycosylation. Three are in prominent surface locations, close to the sites of cellular receptor attachment and to neutralizing epitopes on or near protrusions surrounding the three-fold axes, raising the possibility that AAV-2 might use glycosylation as a means of immune escape or for preventing reattachment on release of progeny virus. Peptide mapping and structural analysis by Fourier transform ion cyclotron resonance mass spectrometry demonstrates, however, no glycosylation of the capsid protein for virus prepared in cultured HeLa cells.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Endoproteinase Asp-N aus Pseudomonas fragi mutant strain, suitable for protein sequencing, lyophilized powder